Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cardiovascular function
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Downloads

Refine by
Date

  • Older

Cardiovascular Function Articles & Analysis: Older

8 news found

Alfa Chemistry Expands Portfolio with High-Purity Marine and Plant-Derived Bioactive Peptides

Alfa Chemistry Expands Portfolio with High-Purity Marine and Plant-Derived Bioactive Peptides

This expansion underscores Alfa Chemistry's commitment to supporting innovation in nutraceuticals, cosmeceuticals, functional foods, and biomedical research. Hydrolyzed peptides, derived from proteins broken down into smaller, more bioavailable chains of amino acids, are increasingly recognized for their targeted functional benefits - ranging from enhanced skin ...

ByAlfa Chemistry


Alfa Chemistry Expands into Marine Chemistry: A Dive into Marine Extracts, Oils, and Natural Products

Alfa Chemistry Expands into Marine Chemistry: A Dive into Marine Extracts, Oils, and Natural Products

Algae along with other marine plants serve vital functions within ecosystems through their substantial role in photosynthesis. ...

ByAlfa Chemistry


Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients   

Alfa Chemistry Integrates Its Supply of Dietary Supplement Ingredients  

Alfa Chemistry's dietary supplement ingredients supply encompasses a wide range of products, including functional ingredients, herbs and botanical extracts, health digestion aids, and food additives. ...

ByAlfa Chemistry


Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors

Bodyport Appoints Amit Rushi as Chief Commercial Officer and Phyllis Whiteley, Ph.D. as Chair of the Board of Directors

Prior to this, Amit established the Digital Health function at Medtronic Diabetes, building the data science team to drive business and product strategy. He also served on the Board of Glooko, representing Medtronic’s corporate venture investment, and led commercial functions in the Cardiovascular Division, launching multiple products and ...

ByBodyport Inc.


ELIXIR MEDICAL COMPLETES ENROLLMENT IN BIOADAPTOR RANDOMIZED CONTROLLED TRIAL OF DYNAMX CORONARY BIOADAPTOR SYSTEM

ELIXIR MEDICAL COMPLETES ENROLLMENT IN BIOADAPTOR RANDOMIZED CONTROLLED TRIAL OF DYNAMX CORONARY BIOADAPTOR SYSTEM

– February 15, 2022 – Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, today announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT). The BIOADAPTOR RCT is evaluating the DynamX™ Coronary Bioadaptor System, the first drug-eluting coronary artery implant that adapts to vessel physiology, allowing for ...

ByElixir Medical Corporation


Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging

Longeveron Announces Publication of Lomecel-B Phase 2b Trial Design in Journal of Frailty and Aging

Inflammation can contribute to the physical decline in Aging Frailty through multiple mechanisms, including detrimental effects on muscles, bone tissue, the immune system, cardiovascular function, and cognition. The necessity for identifying patients with Aging Frailty is well-acknowledged in the geriatric community, and the treatment of Aging Frailty and ...

ByLongeveron, Inc.


CVRx`s BAROSTIM NEO Receives CMS NTAP Effective October 1, 2020

CVRx`s BAROSTIM NEO Receives CMS NTAP Effective October 1, 2020

Designed to treat patients by electrically activating the baroreflex, the body's natural mechanism to regulate cardiovascular function, BAROSTIM NEO uses CVRx-patented technology to send electrical pulses to baroreceptors located in the wall of the carotid artery, to deliver BAROSTIM THERAPY™. ...

ByCVRx


News release: CVRx Raises $50 Million in New Equity Financing

News release: CVRx Raises $50 Million in New Equity Financing

The BAROSTIM NEO is designed to treat these patients by electrically activating the baroreflex, the body’s natural mechanism to regulate cardiovascular function. The BAROSTIM NEO device is the world’s first neuromodulation device approved for heart failure patients. ...

ByCVRx

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT